Downstream Issues Still Beset Production
To Protect the Bottom Line, Biomanufacturers Invest in Downstream Purification Technology
GEN Roundup: No Detail Is Too Small in Bioprocess Scaleup
A Change in Scale Can Change Everything
Amid Election Clamor, Research Issues Surface
Sounds of Science Podcast
10 Takeover Targets of 2016
Which Biopharmas Do Wall Street Watchers View As Top Buyout Candidates?
For full access to this article login to GEN Select now.
Vaccine Development Aided by New Techniques
Field Revitalized by In-Depth Understanding of Infectious Diseases and Immunology
- The cyclical fortunes that have characterized the vaccines business for decades have swung decidedly positive, with no indication that they will slip again any time soon. Today, vaccine development and manufacturing, more than perhaps any other area of biotechnology, are characterized by innovation, even daring. Developers tackle not ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.